Eloralintide
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight
Eli Lilly · Phase 1 · Recruiting · Enrollment 56
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Eloralintide Cohort 1 | Obesity or overweight | n/r | n/r | n/r | n/r |
| Eloralintide Cohort 2 | Obesity or overweight | n/r | n/r | n/r | n/r |
| Eloralintide Cohort 3 | Obesity or overweight | n/r | n/r | n/r | n/r |
| Eloralintide Cohort 4 | Obesity or overweight | n/r | n/r | n/r | n/r |
| Placebo | Obesity or overweight | n/r | n/r | n/r | n/r |